NCT03463330

Brief Summary

The purpose of this study is to learn the effects of two mild body exercises on quality of life, non-motor symptoms, anxiety, depression, fatigue, sleep quality, cognition, and executive function on people with Parkinson's Disease (PD).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 13, 2018

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

January 21, 2022

Status Verified

January 1, 2022

Enrollment Period

4.6 years

First QC Date

March 6, 2018

Last Update Submit

January 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Parkinson's Disease Sleep Scale (PDSS-2)

    This instrument has a total range of scores between 0 and 60. The lower the score the better.

    Change from Baseline to Week 12

Secondary Outcomes (13)

  • Parkinson's Disease Questionnaire (PDQ-39)

    Change from Baseline to Week 12

  • Non Motor Symptom Questionnaire (NMSQuest)

    Change from Baseline to Week 12

  • Geriatric Anxiety Scale (GAS-10)

    Change from Baseline to Week 12

  • Geriatric Depression Scale (GDS-15)

    Change from Baseline to Week 12

  • Parkinson Fatigue Scale (PFS-16)

    Change from Baseline to Week 12

  • +8 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participation in the intervention group will involve a total of 14 visits over about 14 weeks to the study site, and then a 6-month follow-up evaluation. Participants will learn and practice the Qigong exercise during the study.

Behavioral: Qigong exercise

Control Group

SHAM COMPARATOR

Participation in the intervention group will involve a total of 14 visits over about 14 weeks to the study site, and then a 6-month follow-up evaluation. Participants will learn and practice a mild body exercise during the study.

Behavioral: Mild body exercise

Interventions

Qigong exerciseBEHAVIORAL

The Qigong exercise is a series of mild exercise movements.

Intervention Group

Participants will be taught of series of similar movements to the Qigong exercise.

Control Group

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic PD
  • Currently taking levodopa with some improvement in motor symptoms, and on a stable dose for a minimum of 4 weeks prior to starting the study
  • Hoehn \& Yahr stage I to III (mild to moderate PD)

You may not qualify if:

  • Mini Mental State Examination (MMSE) score \< 24
  • Central neurological diseases other than PD or prior major head trauma with loss of consciousness, including other forms of parkinsonism, uncontrolled or significant cardiovascular diseases, orthopedic or medical problems that would interfere with gait
  • Being primarily wheelchair bound
  • Deep brain stimulation
  • Expected change in PD medications over the course of the study
  • Subjects with MRI contraindications such as pacemaker, aneurysm clips, artificial heart valves, metal fragments, foreign objects or claustrophobia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Related Publications (4)

  • Moon S, Sarmento CVM, Colgrove Y, Liu W. Complementary Health Approaches for People With Parkinson Disease. Arch Phys Med Rehabil. 2020 Aug;101(8):1475-1477. doi: 10.1016/j.apmr.2020.03.024. Epub 2020 Jul 3. No abstract available.

    PMID: 32631594BACKGROUND
  • Moon S, Sarmento CVM, Smirnova IV, Colgrove Y, Lyons KE, Lai SM, Liu W. Effects of Qigong Exercise on Non-Motor Symptoms and Inflammatory Status in Parkinson's Disease: A Protocol for a Randomized Controlled Trial. Medicines (Basel). 2019 Jan 18;6(1):13. doi: 10.3390/medicines6010013.

    PMID: 30669324BACKGROUND
  • Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.

  • Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.

Related Links

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Wen Liu, PhD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Qigong exercise in intervention arm and mild body exercise in control arm
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2018

First Posted

March 13, 2018

Study Start

July 5, 2017

Primary Completion

February 1, 2022

Study Completion

March 1, 2022

Last Updated

January 21, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share

We will share all IPD data that underlie results in our publications.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The shared information will be available in our lab webpage 6 months after publication.
Access Criteria
The data will be shared with researchers who plan to conduct meta analysis. The PI will review any request for data sharing and make decisions on data sharing.
More information

Locations